HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Helene Curtis Suave hand and body lotion posts double-digit market share gains in FY 1995.

This article was originally published in The Rose Sheet

Executive Summary

HELENE CURTIS DOUBLE DIGIT SHARE GAINS IN LOTIONS AND DEODORANTS contributed to a 5% increase in U.S sales for FY 1995 (ended Feb. 28), according to year-end results released by the company April 3. Curtis reported double-digit increases in market share for the Suave hand and body lotions -- which were expanded in September with a therapeutic skin treatment -- and for Degree antiperspirant and deodorant, which added Spring Fresh and Aqua Cool scents in 1994. In addition, the nine-SKU Suave Baby Care line, launched in the first quarter is progressing "toward its goal of 5 percent market share in its first full year," Curtis said

You may also be interested in...

Teva Leapfrogs Mylan And Sandoz On Linaclotide

A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.

Tecentriq Disappoints In Post-Surgery Bladder Cancer

Failure is a knock-back for the blockbuster product, but Tecentriq has many more opportunities for trial success in 2020.

Tiofarma Admits Involvement On UK Fludrocortisone

Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts